Robert Fracisco v. Pfizer, Inc | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Robert Fracisco v. Pfizer, Inc

Sort by

Viewing results 1‒25 of 206

BlackRock Inc
BlackRock steps up security for Larry Fink after ‘anti-woke’ backlash
...targeted for periodic protests by climate activists who say it has not done enough to promote decarbonisation.In 2022, the asset manager set up personal security plans for Fink and BlackRock president Robert...
April 21, 2024
Mergers & Acquisitions
M&A crackdown a ‘disaster’ for pharma sector, Pfizer executive warns
...Earlier at the conference, Amgen chief executive Robert Bradway expressed confidence his company would succeed in closing its acquisition of Horizon despite the FTC’s opposition....
May 17, 2023
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Mergers & Acquisitions
Merck buys Prometheus Biosciences for almost $11bn
...In March Pfizer swooped on Seagen, announcing a deal for a total enterprise value of $43bn, which was the largest pharmaceutical transaction announced since AbbVie agreed to buy Allergan in 2019....
April 16, 2023
Covid-19 vaccines
US approves Omicron vaccines from Moderna and BioNTech/Pfizer
...Robert Califf, head of the FDA, said the regulator strongly encouraged anyone eligible “to consider receiving a booster dose with a bivalent Covid-19 vaccine to provide better protection against currently...
August 31, 2022
HSBC Holdings PLC
HSBC to leave longtime New York headquarters for new west side tower
...Tishman Speyer, one of New York’s largest commercial property developers, had previously secured pharmaceuticals company Pfizer as its anchor tenant for the Spiral....
May 2, 2022
Covid-19 vaccines
Pfizer and Moderna forecast to almost double vaccine sales in 2022
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
October 18, 2021
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
FT MagazineRobert Shrimsley
What the Royal Family could learn from Apple
...Follow Robert on Twitter @robertshrimsley and email him at robert.shrimsley@ft.com Follow @FTMag on Twitter to find out about our latest stories first...
January 14, 2022
Covid-19 vaccines
Vaccines work well against variant found in India, data show
...Dr Robert Challen of the University of Exeter, whose modelling of the variant from India was presented to the government’s scientific advisory group, Sage, said it was hard to reach a definitive conclusion...
May 22, 2021
Covid-19 vaccines
Africa will pay more for Russian Covid vaccine than ‘western’ jabs
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
February 25, 2021
#techFT
V for vendetta and volatility
...We have a blow-by-blow explanation of how this “short squeeze” has developed and Robert Armstrong has answers to the key questions, such as whether this will end badly. “Definitely,” he says....
January 29, 2021
News in-depthCovid-19 vaccines
Should children be vaccinated to slow the spread of coronavirus?
...Robert Frenck, principal investigator for trials on under-12s of the BioNTech/ Pfizer jab at the Cincinnati Children’s Hospital Medical Center, said he expected children over the age of 12 to be vaccinated...
May 7, 2021
FT AlphavilleCoronavirus
The ESG case for the Oxford/AstraZeneca vaccine
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
December 23, 2020
Coronavirus treatment
EU fast-tracks process for Pfizer and BioNTech’s Covid-19 vaccine
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
October 6, 2020
FT Swamp Notes
Covid and the rebirth of US industrial policy Premium content
...It was their company, BioNTech, that produced the Pfizer vaccine....
December 18, 2020
The Long ViewMichael Mackenzie
The coming earnings season could bring lofty stocks down to earth
...The global equity strategy team at Citi, led by Robert Buckland, say stocks around the world may well be stuck over the next 12 months....
July 11, 2020
FT Live
Due Diligence Live
Where leaders in investment and finance meet
Tuesday, 8 OctoberLondon, UK
News in-depthRetail sector
Lockdown home improvement boom boosts US DIY chains
...But sales of the Ariens Ikon XD, featuring 20-inch tyres, a V-twin Kawasaki engine and ergonomic plush seat, have surged in the US during the pandemic....
August 22, 2020
Due Diligence
The line between private equity and plundering Premium content
...So the biggest groups — including Roberts and Kravis’ KKR, which reported bumper results on Tuesday — are moving into insurance....
August 5, 2020
Inside BusinessRobert Armstrong
Banks are forecasting on gut instinct — just like the rest of us
...“I would say that, as a team, we've pretty well discounted a uniform V-shaped recovery. The question is, is it U-shaped, is it W-shaped or parts of it L-shaped?”...
April 20, 2020
Tail RiskRobin Wigglesworth
‘Crazy’ stocks keep driving higher while fundamentals weaken
...Deutsche Bank’s satellite-powered shipping tracker indicates that Chinese economic activity has now stopped contracting, and some economists are predicting a V-shaped recovery....
February 21, 2020
Disrupted Times
Investors seek signs of US economic recovery as virus spreads
...US finance editor Robert Armstrong considers which trends are telling the real story in this video....
July 13, 2020
Coronavirus
J&J and Abbott flag potential vaccine and rapid test
...Since then companies including Sanofi, GSK and Pfizer have begun to compete — though none of them have yet tested their potential vaccines in humans....
March 30, 2020
Due Diligence
Bob Iger: the legacy of Disney’s daring dealmaker Premium content
...We did this two years ago when Ian Read, the Scottish-born accountant turned businessman, announced his plans to step down as chief executive of pharmaceuticals group Pfizer....
February 27, 2020
Pfizer Inc
Pfizer and Mylan set to merge off-patent drugs businesses
...If the deal goes through, Michael Goettler, who runs Upjohn, Pfizer’s off-patent drugs business based in Shanghai, will become chief executive of the new venture, while Robert Coury, Mylan’s chairman, would...
July 27, 2019
Pfizer Inc
Pfizer and Mylan to combine off-patent drugs businesses
...Michael Goettler, Upjohn’s president, will be chief executive of the new company while Robert Coury, Mylan’s chairman, will be executive chairman....
July 29, 2019
Due Diligence
Will big banks ever make money in China? Premium content
...Xerox wants to give HP’s board its walking papers We’re all guilty of overusing the David v Goliath trope but in the case of Xerox and HP, it really does apply....
January 24, 2020

Previous pagePage 1 of 9Next page